Global Cannabidiol Market Growth, Size, Trends Analysis- By Source Type, By Sales Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Cannabidiol Market Introduction and Overview

According to SPER market research, 'Global Cannabidiol Market Size- By Component, By Industry - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Cannabidiol Market is predicted to reach 40.01 billion by 2034 with a CAGR 16.06%.

Cannabidiol, or CBD, is a natural compound derived from the cannabis plant. Unlike THC, its more famous counterpart, CBD is non-psychoactive and does not cause a "high." In recent years, it has gained widespread attention for its potential health benefits, such as easing pain, reducing inflammation, alleviating anxiety, and controlling seizures. CBD works by interacting with the body's endocannabinoid system, which plays a role in regulating mood, sleep, and immune function.

Restraints: The cannabidiol (CBD) oil market faces numerous challenges that could hinder its growth and progress. One of the biggest obstacles is regulatory uncertainty, as laws governing CBD products differ significantly across regions and can change quickly, causing confusion for both manufacturers and consumers. Issues with quality control and product consistency, including varying potency and potential contamination, also undermine consumer confidence.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Source Type, By Sales Type, By End Use

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered ENDOCA, NuLeaf Naturals, LLC, Isodiol International, Inc., PharmaHemp, The Cronos Group, Cannoid, LLC, Medical Marijuana, Inc., Folium Europe B.V., Canopy Growth Corporation, Elixinol.

Global Cannabidiol Market Segmentation:

By Source Type: Based on the Source Type, Global Cannabidiol Market is segmented as; Hemp, Marijuana.

By Sales Type: Based on the Sales Type, Global Cannabidiol Market is segmented as; B2B, B2C, By Sales Channel, Hospital Pharmacies, Online, Retail Stores.

By End Use: Based on the End Use, Global Cannabidiol Market is segmented as; Medical, Personal Use, Pharmaceuticals, Wellness, Food & Beverages, Personal Care & Cosmetics, Nutraceuticals, Others

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Product Code: PHAR2516

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Cannabidiol Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cannabidiol Market

7. Global Cannabidiol Market, By Source Type, (USD Million) 2021-2034

7.1. Hemp
7.2. Marijuana

8. Global Cannabidiol Market, By Sales Type, (USD Million) 2021-2034

8.1. B2B
8.2. B2C
8.3. By Sales Channel
8.4. Hospital Pharmacies
8.5. Online
8.6. Retail Stores

9. Global Cannabidiol Market, By End Use, (USD Million) 2021-2034

9.1. Medical
- 9.1.1. Chronic Pain
- 9.1.2. Mental Disorders
- 9.1.3. Cancer
- 9.1.4. Others
9.2. Personal Use
9.3. Pharmaceuticals
9.4. Wellness
9.5. Food & Beverages
9.6. Personal Care & Cosmetics
9.7. Nutraceuticals
9.8. Others

10. Global Cannabidiol Market, (USD Million) 2021-2034

10.1. Global Cannabidiol Market Size and Market Share

11. Global Cannabidiol Market, By Region, 2021-2034 (USD Million)

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. ENDOCA
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Cannoid, LLC
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Medical Marijuana, Inc.
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Folium Europe B.V.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Canopy Growth Corporation
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Elixinol
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. NuLeaf Naturals, LLC
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Isodiol International, Inc
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. PharmaHemp
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. The Cronos Group
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others